ICTRP Search Portal

Main

Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.

Register:	ClinicalTrials.gov
Last refreshed on:	19 February 2015
Main ID:	NCT02272673
Date of registration:	19/10/2014
Prospective Registration:	No
Primary sponsor:	Ain Shams University
Public title:	The Effects of Honey on Febrile Neutropenia in Children With Acute Lymphoblastic Leukemia
Scientific title:	The Effect of Honey on Episodes of Febrile Neutropenia in Children With Acute Lymphoblastic Leukemia: A Randomized Crossover Open- Labeled Pilot Study
Date of first enrolment:	March 2011
Target sample size:	40
Recruitment status:	Completed
URL:	http://clinicaltrials.gov/show/NCT02272673
Study type:	Observational
Study design:	Observational Model: Case-Crossover, Time Perspective: Prospective
Phase:

Countries of recruitment
Egypt

Contacts

Name:	Nouran A Hassanen, M.B.B.Ch
Address:
Telephone:
Email:
Affiliation:	Pediatric department, Faculty of Medicine, Ain Shams University

Name:	Ahmad A Hamed, Dr
Address:
Telephone:
Email:
Affiliation:	Pediatric department, Faculty of Medicine, Ain Shams University

Name:	Sahar A Mohamed, Dr
Address:
Telephone:
Email:
Affiliation:	Faculty of Medicine, El-Azhar University

Key inclusion & exclusion criteria

Inclusion Criteria:

- All patients > 2 years of age with acute lymphoblastic leukemia (ALL), treated
according to the Modified CCG 1991 protocol for standard- risk ALL and on maintenance
therapy

Exclusion Criteria:

- Patients with diabetes mellitus (DM) and patients who had febrile neutropenia at the
time enrollment were excluded from the study.

Age minimum: 2 Years
Age maximum: 12 Years
Gender: Both

Health Condition(s) or Problem(s) studied

Acute Lymphoblastic Leukemia

Intervention(s)

Dietary Supplement: Honey

Primary Outcome(s)

Febrile neutropenia: composite (febrile neutropenia in terms of frequency and duration of hospital stay) [Time Frame: 3 months]

Secondary Outcome(s)

Secondary ID(s)

1/2011

Source(s) of Monetary Support

Please refer to primary and secondary sponsors

Secondary Sponsor(s)

Ethics review

Results

Results available:
Date Posted:
Date Completed:
URL:

Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.